Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten J Maier

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Vaccines|May 28, 2022
The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster VaccinationFlorian D Hastert, Sascha Hein, Christine von Rhein, et al.
Cellular Signalling|September 17, 2013
5-Lipoxygenase contributes to PPARγ activation in macrophages in response to apoptotic cellsAndreas von Knethen, Lisa K Sha, Laura Kuchler, et al.
NPJ Vaccines|March 18, 2025
Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19Aileen Ebenig, Mona V Lange, Michelle Gellhorn Serra, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 31, 2009
Cellular membranes function as a storage compartment for celecoxibThorsten J Maier, Susanne Schiffmann, Ivonne Wobst, et al.
Biochimica Et Biophysica Acta|June 14, 2015
5-Lipoxygenase is a direct p53 target gene in humansBianca Gilbert, Khalil Ahmad, Jessica Roos, et al.
International Journal of Molecular Sciences|August 26, 2022
Red Blood Cell-Derived Microparticles Exert No Cancer Promoting Effects on Colorectal Cancer Cells In VitroDania Fischer, Fabian Thies, Omar Awad, et al.
Molecular Pharmacology|April 13, 2013
Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cellsMelania Dovizio, Thorsten J Maier, Sara Alberti, et al.
Biochemical Pharmacology|August 12, 2008
Celecoxib inhibits 5-lipoxygenaseThorsten J Maier, Lars Tausch, Michael Hoernig, et al.
Vaccines|May 28, 2022
Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth VaccinationSascha Hein, Ines Mhedhbi, Tobias Zahn, et al.
Frontiers in Pharmacology|February 7, 2022
Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin TransportAstrid S Kahnt, Carlo Angioni, Tamara Göbel, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Vaccines|May 28, 2022
The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster VaccinationFlorian D Hastert, Sascha Hein, Christine von Rhein, et al.
Cellular Signalling|September 17, 2013
5-Lipoxygenase contributes to PPARγ activation in macrophages in response to apoptotic cellsAndreas von Knethen, Lisa K Sha, Laura Kuchler, et al.
NPJ Vaccines|March 18, 2025
Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19Aileen Ebenig, Mona V Lange, Michelle Gellhorn Serra, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 31, 2009
Cellular membranes function as a storage compartment for celecoxibThorsten J Maier, Susanne Schiffmann, Ivonne Wobst, et al.
Biochimica Et Biophysica Acta|June 14, 2015
5-Lipoxygenase is a direct p53 target gene in humansBianca Gilbert, Khalil Ahmad, Jessica Roos, et al.
International Journal of Molecular Sciences|August 26, 2022
Red Blood Cell-Derived Microparticles Exert No Cancer Promoting Effects on Colorectal Cancer Cells In VitroDania Fischer, Fabian Thies, Omar Awad, et al.
Molecular Pharmacology|April 13, 2013
Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cellsMelania Dovizio, Thorsten J Maier, Sara Alberti, et al.
Biochemical Pharmacology|August 12, 2008
Celecoxib inhibits 5-lipoxygenaseThorsten J Maier, Lars Tausch, Michael Hoernig, et al.
Vaccines|May 28, 2022
Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth VaccinationSascha Hein, Ines Mhedhbi, Tobias Zahn, et al.
Frontiers in Pharmacology|February 7, 2022
Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin TransportAstrid S Kahnt, Carlo Angioni, Tamara Göbel, et al.
Pageof 5